|
|
.
See Category: Diseases of the genitourinary system
ICD-10 (CM) Code and Descriptor
|
N32.9 |
Bladder disorder, unspecified
|
N329 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 28.67%
|
26.03%
|
14.57%
|
9.02%
|
5.58%
|
3.83%
|
2.47%
|
2.24%
|
1.53%
|
1.32%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for N32.9*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
1,478
|
1,927
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
1,218
|
28,481
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,208
|
1,622
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,174
|
1,192
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
1,165
|
109,315
|
|
J2405
|
ONDANSETRON HCL INJECTION |
1,150
|
4,735
|
|
87086
|
URINE CULTURE/COLONY COUNT |
1,113
|
1,114
|
|
81001
|
URINALYSIS AUTO W/SCOPE |
970
|
975
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
954
|
956
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
917
|
921
|
|
52000
|
CYSTOURETHROSCOPY |
824
|
824
|
|
J0690
|
CEFAZOLIN SODIUM INJECTION |
771
|
2,946
|
|
80048
|
METABOLIC PANEL TOTAL CA |
728
|
729
|
|
74178
|
CT ABD&PLV WO CNTR FLWD CNTR |
724
|
724
|
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
719
|
4,650
|
|
80053
|
COMPREHEN METABOLIC PANEL |
651
|
651
|
|
52204
|
CYSTOSCOPY W/BIOPSY(S) |
639
|
639
|
|
88112
|
CYTOPATH CELL ENHANCE TECH |
616
|
638
|
|
J7120
|
RINGERS LACTATE INFUSION |
555
|
678
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
551
|
1,408
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
N32.9 related to the following DRG Codes:
698-700
|
